0000899243-20-001092.txt : 20200113 0000899243-20-001092.hdr.sgml : 20200113 20200113171724 ACCESSION NUMBER: 0000899243-20-001092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200109 FILED AS OF DATE: 20200113 DATE AS OF CHANGE: 20200113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Batycky Richard P. CENTRAL INDEX KEY: 0001646596 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36199 FILM NUMBER: 20524359 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulmatrix, Inc. CENTRAL INDEX KEY: 0001574235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461821392 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 390 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-2333 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: SUITE 390 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Ruthigen, Inc. DATE OF NAME CHANGE: 20130411 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-09 0 0001574235 Pulmatrix, Inc. PULM 0001646596 Batycky Richard P. C/O PULMATRIX, INC., 99 HAYDEN AVE, SUITE 390 LEXINGTON MA 02421 1 0 0 0 Stock Option (Right to Buy) 1.54 2020-01-09 4 A 0 30000 0.00 A 2030-01-09 Common Stock 30000 30000 D Twenty-five percent (25%) of this option will vest and become exercisable on November 1, 2020 (the "First Vesting Date"), and the remaining shares underlying the option will vest and become exercisable in thirty-six (36) equal monthly installments on each monthly anniversary of the First Vesting Date thereafter, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. /s/ Richard Batycky 2020-01-13